Literature DB >> 14597606

Pharmacological characterisation of a rat model of incisional pain.

Garth T Whiteside1, James Harrison, Jamie Boulet, Lilly Mark, Michelle Pearson, Susan Gottshall, Katharine Walker.   

Abstract

1. Both clinical and preclinical models of postsurgical pain are being used more frequently in the early evaluation of new chemical entities. In order to assess the validity and reliability of a rat model of postincisional pain, the effects of different classes of clinically effective analgesic drugs were evaluated against multiple behavioural end points. 2. Following surgical incision, under general anaesthesia, of the plantar surface of the rat hind paw, we determined the time course of mechanical hyperalgesia, tactile allodynia and hind limb weight bearing using the Randall-Selitto (paw pressure) assay, electronic von Frey and dual channel weight averager, respectively. Behavioural evaluations began 24 h following surgery, and were continued for 9-14 days. 3. Mechanical hyperalgesia, tactile allodynia and a decrease in weight bearing were present on the affected limb within 1 day of surgery with maximum sensitivity 1-3 days postsurgery. Accordingly, we examined the effect of nonsteroidal antiinflammatory drugs (NSAIDs), morphine and gabapentin, on established hyperalgesia and allodynia, 1 day following plantar incision.4. In accordance with previous reports, both systemic morphine and gabapentin administration reversed mechanical hyperalgesia and tactile allodynia in the incised rat hind paw. Both drugs were more potent against mechanical hyperalgesia than tactile allodynia. 5. All of the NSAIDs tested, including cyclooxygenase 2 selective inhibitors, reversed mechanical hyperalgesia and tactile allodynia in the incised rat hind paw. The rank order of potency for both hyperalgesia and allodynia was indomethacin > celecoxib > etoricoxib > naproxen. 6. We have investigated the potency and efficacy of different classes of analgesic drugs in a rat model of postincisional pain. The rank order of potency for these drugs reflects their utility in treating postoperative pain in the clinic. As these compounds showed reliable efficacy across two different behavioural end points, the Randall-Selitto (paw pressure) assay and electronic von Frey, these methods may prove useful in the study of postsurgical pain and the assessment of novel treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597606      PMCID: PMC1574164          DOI: 10.1038/sj.bjp.0705568

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  The role of heme oxygenase in neuropathic and incisional pain.

Authors:  X Li; J D Clark
Journal:  Anesth Analg       Date:  2000-03       Impact factor: 5.108

2.  Enadoline, a selective kappa-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain.

Authors:  M J Field; A J Carnell; M I Gonzalez; S McCleary; R J Oles; R Smith; J Hughes; L Singh
Journal:  Pain       Date:  1999-03       Impact factor: 6.961

3.  The role of the spinal opioid receptor like1 receptor, the NK-1 receptor, and cyclooxygenase-2 in maintaining postoperative pain in the rat.

Authors:  T Yamamoto; Y Sakashita
Journal:  Anesth Analg       Date:  1999-11       Impact factor: 5.108

4.  Effects of intrathecal administration of ziconotide, a selective neuronal N-type calcium channel blocker, on mechanical allodynia and heat hyperalgesia in a rat model of postoperative pain.

Authors:  Y X Wang; M Pettus; D Gao; C Phillips; S Scott Bowersox
Journal:  Pain       Date:  2000-02       Impact factor: 6.961

5.  Primary and secondary hyperalgesia in a rat model for human postoperative pain.

Authors:  P K Zahn; T J Brennan
Journal:  Anesthesiology       Date:  1999-03       Impact factor: 7.892

Review 6.  [Postoperative patient management. Pain after surgical intervention].

Authors:  M Chauvin
Journal:  Presse Med       Date:  1999-01-30       Impact factor: 1.228

7.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

Authors:  T D Warner; F Giuliano; I Vojnovic; A Bukasa; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

8.  Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of postoperative pain.

Authors:  J K Cheng; H L Pan; J C Eisenach
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

9.  Incision-induced changes in receptive field properties of rat dorsal horn neurons.

Authors:  P K Zahn; T J Brennan
Journal:  Anesthesiology       Date:  1999-09       Impact factor: 7.892

10.  Intrathecal adenosine: interactions with spinal clonidine and neostigmine in rat models of acute nociception and postoperative hypersensitivity.

Authors:  A I Chiari; J C Eisenach
Journal:  Anesthesiology       Date:  1999-05       Impact factor: 7.892

View more
  48 in total

1.  Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.

Authors:  Emmanuel Bourinet; Abdelkrim Alloui; Arnaud Monteil; Christian Barrère; Brigitte Couette; Olivier Poirot; Anne Pages; John McRory; Terrance P Snutch; Alain Eschalier; Joël Nargeot
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

2.  Antinociceptive effects of sinomenine in a rat model of postoperative pain.

Authors:  Qing Zhu; Yuehua Sun; Lina Mao; Chengpeng Liu; Bo Jiang; Wei Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2016-03-31       Impact factor: 8.739

3.  Use of Flavored Tablets of Gabapentin and Carprofen to Attenuate Postoperative Hypersensitivity in an Incisional Pain Model in Rats (Rattus norvegicus).

Authors:  Brian P Zude; Katechan Jampachaisri; Cholawat Pacharinsak
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-02-19       Impact factor: 1.232

4.  Selective inhibition of CaV3.2 channels reverses hyperexcitability of peripheral nociceptors and alleviates postsurgical pain.

Authors:  Sonja L Joksimovic; Srdjan M Joksimovic; Vesna Tesic; Agustin García-Caballero; Simon Feseha; Gerald W Zamponi; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  Sci Signal       Date:  2018-08-28       Impact factor: 8.192

5.  α-Spinasterol: a COX inhibitor and a transient receptor potential vanilloid 1 antagonist presents an antinociceptive effect in clinically relevant models of pain in mice.

Authors:  Indiara Brusco; Camila Camponogara; Fabiano Barbosa Carvalho; Maria Rosa Chitolina Schetinger; Mauro Schneider Oliveira; Gabriela Trevisan; Juliano Ferreira; Sara Marchesan Oliveira
Journal:  Br J Pharmacol       Date:  2017-10-18       Impact factor: 8.739

6.  Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.

Authors:  Dong Wook Lim; Jae Goo Kim; Eun Yeong Lim; Yun Tai Kim
Journal:  Inflammopharmacology       Date:  2017-08-28       Impact factor: 4.473

7.  Semi-mechanistic modelling of the analgesic effect of gabapentin in the formalin-induced rat model of experimental pain.

Authors:  A Taneja; I F Troconiz; M Danhof; O Della Pasqua
Journal:  Pharm Res       Date:  2013-10-05       Impact factor: 4.200

8.  Evaluation of buprenorphine in a postoperative pain model in rats.

Authors:  Leslie I Curtin; Julie A Grakowsky; Mauricio Suarez; Alexis C Thompson; Jean M DiPirro; Lisa B E Martin; Mark B Kristal
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  Effect of tramadol on immune responses and nociceptive thresholds in a rat model of incisional pain.

Authors:  Yong-Min Liu; Sheng-Mei Zhu; Kui-Rong Wang; Zhi-Ying Feng; Qing-Lian Chen
Journal:  J Zhejiang Univ Sci B       Date:  2008-11       Impact factor: 3.066

10.  Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis.

Authors:  Michael K Boettger; Johannes Leuchtweis; Diana Kümmel; Mieczyslaw Gajda; Rolf Bräuer; Hans-Georg Schaible
Journal:  Arthritis Res Ther       Date:  2010-07-13       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.